This message was posted by a user wishing to remain anonymous
Dear Members ,
We have some studies available for our products that our product can be administered via G-tube ( enteral feeding tube) . So now wanted guidance which all sections the information regarding administration via G-tube needs to be mentioned Iin the products SPC and PIL while filing the variation in Europe .
Also since G -tube will not be supplied by us along with the pack only information that our product can be administered via G-tube is to be included which type of variation in Europe this variation will classify ?